Full text is available at the source.
Abstract
No real-world studies have examined clinical outcomes of liraglutide for type 2 diabetes in adolescents.
- Liraglutide is an approved medication for treating type 2 diabetes in children.
- Previous research has focused primarily on adults rather than adolescents.
- Clinical outcomes in adolescent populations remain largely unexplored.
- Further investigation may be necessary to understand liraglutide's effectiveness and safety in younger patients.
Simplified